A break through in stopping snoring

A once-a-night pill could see the end of snoring.

The tablet – called AD109 – has been developed by pharmaceutical company Apnimed.

It’s to treat Obstructive Sleep Apnoea – a condition associated with snoring and interrupted breathing at night.

Dr Larry Miller, CEO of Apnimed, said:

“Obstructive Sleep Apnoea represents a significant public health problem around the globe

“Current treatment options do not meet the needs of patients.

“We believe that AD109 could be a significant breakthrough for these patients.”

AD109 is taken at bedtime and can be used to treat patients with mild to severe snoring issues.

Phase 1 trials have been completed and the drug was tolerated, and with no side effects.

Phase 2 starts soon.

 

 


About the Author

Philip Braund spent 16 years at the Daily Mirror as a reporter and news editor before moving to ITV. He was the series producer of the ground-breaking investigation programme The Cook Report, Managing Editor at ITV's Millbank Studios, and Head of News at ITV Central. He has won national and regional Royal Television Society awards for documentaries.



Back to Top ↑